These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 1381789

  • 1. Acute effects of cilazapril on coronary hemodynamics in patients with renovascular hypertension.
    Magrini F, Reggiani P, Fratianni G, Morganti A, Zanchetti A.
    J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S128-33. PubMed ID: 1381789
    [Abstract] [Full Text] [Related]

  • 2. Coronary blood flow in renovascular hypertension.
    Magrini F, Reggiani P, Fratianni G, Morganti A, Zanchetti A.
    Am J Med; 1993 Apr 23; 94(4A):45S-48S. PubMed ID: 8488857
    [Abstract] [Full Text] [Related]

  • 3. Coronary hemodynamics and the renin angiotensin system.
    Magrini F, Reggiani P, Paliotti R, Bonagura F, Ciulla M, Vandoni P.
    Clin Exp Hypertens; 1993 Apr 23; 15 Suppl 1():139-55. PubMed ID: 8513306
    [Abstract] [Full Text] [Related]

  • 4. Effects of chronic ACE inhibition on cardiac hypertrophy and coronary vascular reserve in spontaneously hypertensive rats with developed hypertension.
    Clozel JP, Kuhn H, Hefti F.
    J Hypertens; 1989 Apr 23; 7(4):267-75. PubMed ID: 2524524
    [Abstract] [Full Text] [Related]

  • 5. Effects of ACE inhibition with cilazapril on splanchnic and systemic haemodynamics in man.
    Gasic S, Heinz G, Kleinbloesem C, Korn A.
    Br J Clin Pharmacol; 1989 Apr 23; 27 Suppl 2(Suppl 2):225S-234S. PubMed ID: 2548552
    [Abstract] [Full Text] [Related]

  • 6. Regulation of coronary blood flow during exercise.
    Duncker DJ, Bache RJ.
    Physiol Rev; 2008 Jul 23; 88(3):1009-86. PubMed ID: 18626066
    [Abstract] [Full Text] [Related]

  • 7. Converting-enzyme inhibition and coronary blood flow.
    Magrini F, Shimizu M, Roberts N, Fouad FM, Tarazi RC, Zanchetti A.
    Circulation; 1987 Jan 23; 75(1 Pt 2):I168-74. PubMed ID: 3024863
    [Abstract] [Full Text] [Related]

  • 8. Vascular protection with cilazapril in hypertension.
    Clozel JP, Kuhn H, Hefti F.
    J Cardiovasc Pharmacol; 1992 Jan 23; 19 Suppl 5():S28-33. PubMed ID: 1381792
    [Abstract] [Full Text] [Related]

  • 9. Hemodynamic effects of long-term converting-enzyme inhibition in renal hypertensive rats.
    Salom MG, Salazar FJ, Fenoy FJ, Pinilla JM, Marín N, Quesada T.
    Rev Esp Fisiol; 1990 Jun 23; 46(2):171-6. PubMed ID: 2274701
    [Abstract] [Full Text] [Related]

  • 10. Long-term changes in the response of conductance and resistance coronary vessels to endothelium-dependent and independent vasodilators. A double-blind placebo-controlled study of the effect of a 6-month treatment with cilazapril.
    Di Mario C, Strikwerda S, Gil R, Azar A, Rames A, Serruys PW.
    Ital Heart J; 2000 Oct 23; 1(10):674-83. PubMed ID: 11061364
    [Abstract] [Full Text] [Related]

  • 11. The effects of antihypertensive medications on the physiological response to maximal exercise testing.
    Derman WE, Sims R, Noakes TD.
    J Cardiovasc Pharmacol; 1992 Oct 23; 19 Suppl 5():S122-7. PubMed ID: 1381788
    [Abstract] [Full Text] [Related]

  • 12. Cardiovascular effects of the new angiotensin-converting-enzyme inhibitor, cilazapril, in anesthetized and conscious dogs.
    Holck M, Fischli W, Hefti F, Gerold M.
    J Cardiovasc Pharmacol; 1986 Oct 23; 8(1):99-108. PubMed ID: 2419701
    [Abstract] [Full Text] [Related]

  • 13. Antihypertensive treatment with cilazapril. Resting and exercise blood pressure, hormones and enzymes.
    Breithaupt K, Belz GG, Spielmanns DG, Neis W, Kirchner P.
    Arzneimittelforschung; 1990 Feb 23; 40(2 Pt 1):136-41. PubMed ID: 2159308
    [Abstract] [Full Text] [Related]

  • 14. Cardiac effects of ACE inhibition.
    Lund-Johansen P, Omvik P.
    J Cardiovasc Pharmacol; 1993 Feb 23; 22 Suppl 1():S36-40. PubMed ID: 7507538
    [Abstract] [Full Text] [Related]

  • 15. [Reparative effects of ACE inhibitors on the heart].
    Dietz R, Haberbosch W, Osterziel KJ, Förderer T, Busch C.
    Klin Wochenschr; 1992 Feb 23; 69 Suppl 29():16-24. PubMed ID: 1535402
    [Abstract] [Full Text] [Related]

  • 16. Ca2+ sensitizer superior to catecholamine during myocardial stunning?
    Meyer K, Klocke RC, Schipke JD, Gams E, Korbmacher B.
    Eur J Cardiothorac Surg; 2008 Aug 23; 34(2):326-31. PubMed ID: 18539040
    [Abstract] [Full Text] [Related]

  • 17. Effects of angiotensin and angiotensin blockade on coronary circulation and coronary reserve.
    Magrini F, Reggiani P, Roberts N, Meazza R, Ciulla M, Zanchetti A.
    Am J Med; 1988 Mar 11; 84(3A):55-60. PubMed ID: 3064599
    [Abstract] [Full Text] [Related]

  • 18. Effects of single doses of the converting enzyme inhibitor cilazapril in normal volunteers.
    Fasanella d'Amore T, Bussien JP, Nussberger J, Waeber B, Turini GA, Brunner HR, Kler L, Francis RJ.
    J Cardiovasc Pharmacol; 1987 Jan 11; 9(1):26-31. PubMed ID: 2434790
    [Abstract] [Full Text] [Related]

  • 19. Haemodynamic and hormonal effects of cilazapril in comparison with propranolol in healthy subjects and in hypertensive patients.
    Kleinbloesem CH, Erb K, Essig J, Breithaupt K, Belz GG.
    Br J Clin Pharmacol; 1989 Jan 11; 27 Suppl 2(Suppl 2):309S-315S. PubMed ID: 2527544
    [Abstract] [Full Text] [Related]

  • 20. [The value of angiotensin-converting enzyme inhibitors in the treatment of hypertension].
    Klaus D.
    Z Kardiol; 1988 Jan 11; 77 Suppl 3():73-88. PubMed ID: 3062960
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.